NVAX
Novavax Inc
Price:  
14.02 
USD
Volume:  
8,523,902.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax WACC - Weighted Average Cost of Capital

The WACC of Novavax Inc (NVAX) is 7.4%.

The Cost of Equity of Novavax Inc (NVAX) is 7.65%.
The Cost of Debt of Novavax Inc (NVAX) is 5.50%.

Range Selected
Cost of equity 6.50% - 8.80% 7.65%
Tax rate 0.20% - 0.50% 0.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.3% - 8.6% 7.4%
WACC

Novavax WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.80%
Tax rate 0.20% 0.50%
Debt/Equity ratio 0.12 0.12
Cost of debt 4.00% 7.00%
After-tax WACC 6.3% 8.6%
Selected WACC 7.4%